<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">According to the World Health Organization, more than 300 million people or 4.4% of the world’s population suffer from depression, representing a substantial global health problem. Depression can greatly impact one’s daily life and can lead to suicidal thoughts [
 <xref ref-type="bibr" rid="CR1">1</xref>]. In Malaysia, the overall prevalence of depression ranged from 8 to 12% [
 <xref ref-type="bibr" rid="CR2">2</xref>], but it is seldom prioritised by patients or clinicians. Currently, the combination of pharmacological and non-pharmacological (including self-care or psychotherapeutic approaches) treatments for depression have only moderate to short-term efficacy. Selective serotonin reuptake inhibitors (SSRIs) are first-line antidepressants commonly used in clinical practice, however, they can have poor tolerability, delayed onset of therapeutic effects and limited efficacy in patients with milder depression [
 <xref ref-type="bibr" rid="CR3">3</xref>]. Furthermore, around 50% of patients experience recurrent depression within 6 months after discontinuation of treatments [
 <xref ref-type="bibr" rid="CR4">4</xref>]. Therefore, it is important to develop and establish Traditional Chinese Medicines that can mimic the desirable antidepressants effects with minimal adverse consequences.
</p>
